BRAF and colorectal carcinoma: According to consensus molecular subtypes (CMS), BRAF mutant CRC mainly (up to 70%) belongs to CMS1 (MSI Immune), which has high immune infiltration and better overall survival (OS) but also distributes in other subtypes [44, 45].